Childhood exposure to bacterial toxin may be triggering colorectal cancer epidemic among the young
On Apr. 23, 2025, researchers from the Wellcome Sanger Institute, University of California San Diego and their collaborators…
Biotechnology | CDC | COVID-19 | Diagnostics | Disease | Genomics | NIH | Oncology | Radiology | Women's Health
Annual Report to the Nation Shows Cancer Deaths Continue to Decline
On Apr. 21, 2025, the National Institutes of Health (NIH) reported that overall death rates from cancer declined steadily among…
Agriculture | Biotechnology | COVID-19 | Diagnostics | Energy | Environmental | EPA | FDA | Forestry | Genomics | HIV | Infectious Disease | Influenza | Measles | Nanotechnology | Neurology | NIH | Oncology | Pharmaceutical | Polio | Stem Cell | Therapeutics | USDA | Vaccine | Veterinary | Women's Health
Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
Thousands of people could benefit from new twice-a-day tablet for advanced breast cancer
On Apr. 11, 2025, the UK National Institute for Health and Care Excellence (NICE) recommended capivasertib (also called…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | USDA
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
On Apr. 10, 2025, the U.S. Food and Drug Administration announced it is taking a groundbreaking step to…
Artificial Intelligence | Biotechnology | Diagnostics | Genomics | Infectious Disease | Nanotechnology | Oncology | Therapeutics | U.S. Congress
National Security Commission on Emerging Biotechnology Urges Swift Action to Protect U.S. National Security
On Apr. 8, 2025, the National Security Commission on Emerging Biotechnology delivered its major report and action plan…
Biotechnology | CRISPR | Disease | Genomics | Oncology | Therapeutics
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Measles | Medicine | Neurology | NIH | Oncology | Organ Transplant | Pharmaceutical | Plague | Polio | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
HHS starts layoffs of thousands of workers across its agencies
On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…
Study uncovers key role of RNA modifications in prostate cancer progression
On Mar. 24, 2025, scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto…
More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
Breast cancer is on the rise: data reveal drastic gap in survival rates
On Feb. 24, 2025, breast cancer is the most common cancer in women worldwide, but survival chances vary…
CPRIT awards $68 million in research grants to Texas institutions
On Feb. 19, 2025, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Parental Alcohol Use Linked To Increased Cancer Risk In Children, Texas A&M Researchers Find
On Feb. 19, 2025, research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences has discovered…
Woman in cancer remission for record 19 years after CAR-T immune treatment
On Feb. 17, 2025, researchers from Texas Children’s Hospital in Houston announced that the four year old girl…
Researchers identify DNA changes, biological pathways associated with inherited cancer risk
On Feb. 17, 2025, Stanford researchers have conducted the first large-scale screen of these inherited changes, called single…
Biotechnology | Disease | Genomics | Oncology | Therapeutics
Mutations in two gene pairs point to a promising drug target in 5 percent of adult cancers
On Feb. 5, 2025, scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and…
Biotechnology | Diagnostics | Disease | FDA | Medicine | Neurology | NIH | Oncology | Therapeutics | U.S. Congress | Vaccine | Women's Health
U.S. FDA drops Support improving clinical trial diversity
Jan. 24, 2025, the U.S. Food and Drug Administration (FDA) pulled draft guidance from its website requiring companies…
Chemical | FDA | Materials | Oncology | Pharmaceutical | U.S. Congress
U.S. FDA Revokes Authorization for the Use of Red No. 3 in Food and Ingested Drugs
On Jan. 15, 2025, the U.S. Food and Drug Administration (FDA) announced revoking the authorization for the use…
Agriculture | Artificial Intelligence | Biotechnology | CRISPR | Diagnostics | Genomics | Infectious Disease | Influenza | Medical Device | NIH | Oncology | Therapeutics | Vaccine
U.S. Implements New Export Controls to Address National Security Risks Related to Biotechnology
On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…
Tumour DNA in the blood can predict lung cancer outcome
On Jan. 13, 2025, scientists from the Francis Crick Institute, UCL, UCLH and Personalis announced they have found…
Roswell Park Team Identifies New Cause of Chemotherapy Resistance in Triple-Negative Breast Cancer
On Jan. 10, 2025, researchers at Roswell Park Comprehensive Cancer Center have identified a previously unknown cause of…
Biotechnology | Chemical | Environmental | EPA | Neurology | Oncology | U.S. Congress
EPA Adds Nine Additional PFAS to the Toxics Release Inventory
On Jan. 3, 2025, the U.S. Environmental Protection Agency announced the automatic addition of nine per- and polyfluoroalkyl…
U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk
On Jan. 3, 2025, the U.S. General Dr. Vivek Murthy released a new Surgeon General’s Advisory on Alcohol…
AI can improve ovarian cancer diagnoses
On Jan. 2, 2025, an international study led by researchers at Karolinska Institutet in Sweden shows that AI-based…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
U.S. FDA Approved Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
On Dec. 20, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved BRAFTOVI® (encorafenib)…
Karmanos Cancer Institute First in the World to use FDA-approved Radiofrequency Electromagnetic Device to Treat Liver Cancer
On Dec. 18, 2024, the Barbara Ann Karmanos Cancer Institute announced that the new TheraBionic P1 device, an…
AI-Based Tool Offers Exciting Advancement in Pancreatic Cancer Diagnostics
On Dec. 12, 2024, a study co-lead by researchers from the University of British Columbia, Vancouver General Hospital…
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
Massachusetts General Hospital Received Transformational Gift of $100 Million from Herb Chambers to Revolutionize Cancer Care for Patients and Families
On Dec. 11, 2024, Massachusetts General Hospital (MGH), founding member of the Mass General Brigham healthcare system, announced…
Biotechnology | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved AstraZeneca’s Imfinzi for limited-stage small cell lung cancer
On Dec. 4, 2024, The U.S. Food and Drug Administration (FDA) announced approved of AstraZeneca’s blockbuster drug Imfinzi…
Nanopore direct RNA sequencing finds cancer’s ‘fingerprint’ improved early detection
On Dec. 4, 2024, researchers at the Centre for Genomic Regulation (CRG) in Barcelona announced they had discovered…